Stocktoria

Medicus Pharma Ltd. MDCX

Nasdaq · stock · Pharmaceutical Preparations · website · IPO 2023-10-11 · LEI

Medicus Pharma Ltd. statistics & valuation

Return on capital-27863%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202320242025
Operating margin (%)
202320242025
Return on equity (%)
-478.20% -355.90% 202320242025
Shares outstanding
8.1M 11.8M 25.2M 202320242025
Net debt ($)
202320242025
Share buybacks ($)
202320242025
Return on assets (%)
-280.80% -197.60% -469.90% 202320242025
Free cash flow margin (%)
202320242025
Debt / equity (×)
202320242025
EPS ($)
-$1.53 -$1.16 -$2.74 202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023
Return on assets-469.9%-197.6%-280.8%
Return on equity69990.7%-355.9%-478.2%
Current ratio1.002.332.42

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.